Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | HCID 57742996 | HCID 57742996 | — |
| Reactant | HCID 86631463 | HCID 86631463 | — |
| Reactant | HCID 86631465 | HCID 86631465 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Nitromethane | HCID 6375 | — |
| Product | HCID 53629161 | HCID 53629161 | 55% |
Reaction Steps
In a 100 ml three-necked flask fitted with a magnetic stirrer, under inert atmosphere, 3,5-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-pyrazole-4-carbaldehyde x56 (0.87 g, 3.1 mmol) and ethyl 4-amino-3-(2,3,5-trifluorophenyl)butanoate hydrochloride x60 (synthesized from nitromethane and ethyl 3-(2,3,5-trifluorophenyl)acrylate by the same methodology as described in Kenda et al., J. Med. Chem. (2004), 47, 530-49; 0.94 g, 3.1 mmol) are dissolved in CH2Cl2 (30 ml). Triethylamine (0.86 ml, 6.3 mmol) and NaBH(OAc)3 (1.33 g, 6.3 mmol) are added and the heterogeneous mixture became a solution. After 16 h at room temperature, two additional portions of NaBH(OAc)3 are added (1.6 mmol after 16 h and 3.2 mmol after 48 h) and 1.6 mmol of triethylamine are added after 24 h stirring at room temperature. The reaction is quenched with water and the aqueous phase is extracted three times with diethylether. The combined organic phases are washed with brine, dried over MgSO4, filtered and concentrated to dryness. The crude product is purified by column chromatography on silicagel (CH2Cl2/MeOH/NH4OH: 95/4.5/0.5 (v/v/v)) to afford 0.83 g of 1-({3,5-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-pyrazol-4-yl}methyl)-4-(2,3,5-trifluorophenyl)pyrrolidin-2-one x61.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08178533B2 |
|---|
| Source dataset | uspto-grants-2012_05 |
|---|
| ORD ID | ord-84fed3c32e8f4f1a9d8e17f6cb425f17 |
|---|
| Source note | uspto-grants-2012_05 |
|---|